Restoration® Modular Revision Hip System Post Market Study

NCT00962013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2017-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Restoration® Modular Revision Hip System

Restoration® Modular Revision System

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Steven Barnett, MD · Orthopaedic Specialty Institute

  • Michael W Britt, MD · Orthopaedic Associates of Corpus Christi

  • Kenneth A Greene, MD · Crystal Clinic

  • Steven F Harwin, MD · Beth Israel Medical Center

  • D. Christopher Hikes, MD · Providence Health & Services

  • Kirby Hitt, MD · Scott and White Hospital

  • William Hozack, md · Rothman Institute

  • Frederick Jaffe, MD · Hospital for Joint Diseases

  • Timothy P Lovell, MD · Providence Orthopaedic Specialties

  • Mark R Matthes, MD · Iowa Orthopaedic Center

  • Arthur Malkani, MD · Jewish Hospital Center for Advanced Medicine

  • John Schurman, MD · Kansas Joint and Spine Institute

  • John Wright, MD · New West Sports Medicine and Orthopaedic Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00962013 on ClinicalTrials.gov